Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Continuous Monitoring of Blood Pressure in Spontaneous Intraparenchimal Cerebral Haemorrhage (BP-MONICH)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified October 2013 by Azienda Ospedaliera Sant'Anna
Sponsor:
Information provided by (Responsible Party):
Simone Vidale, Azienda Ospedaliera Sant'Anna
ClinicalTrials.gov Identifier:
NCT01956292
First received: September 29, 2013
Last updated: October 5, 2013
Last verified: October 2013
  Purpose

Evaluation of blood pressure variability in the acute phase of intraparenchimal cerebral haemorrhage and its consequences to clinical outcome


Condition
Intraparenchimal Cerebral Haemorrhage

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Observational Study of Continous Monitoring of Arterial Blood Pressure in Spontaneous Intraparenchimal Cerebral Haemorrhage

Resource links provided by NLM:


Further study details as provided by Azienda Ospedaliera Sant'Anna:

Primary Outcome Measures:
  • evaluation of blood pressure varibility on clinical course in patients with cerebral haemorrhage [ Time Frame: Day 7 ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: October 2013
Estimated Study Completion Date: June 2015
Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Intraparenchimal cerebral haemorrhage

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients admitted to hospital for intraparenchimal cerebral haemorrhage

Criteria

Inclusion Criteria:

  • hospitalization only for spontaneous intraparenchimal cerebral haemorrhage
  • age over 18 years

Exclusion Criteria:

  • cerebral haemorrhage secondary to other causes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01956292

Contacts
Contact: Simone Vidale, MD 00390315859282 simone.vidale@hsacomo.org

Locations
Italy
AO Sant'Anna Hospital Not yet recruiting
Como, Italy, 22100
Contact: Simone Vidale, MD    00390315859282    simone.vidale@hsacomo.org   
Sponsors and Collaborators
Azienda Ospedaliera Sant'Anna
  More Information

No publications provided

Responsible Party: Simone Vidale, M.D., Azienda Ospedaliera Sant'Anna
ClinicalTrials.gov Identifier: NCT01956292     History of Changes
Other Study ID Numbers: OSA-0002
Study First Received: September 29, 2013
Last Updated: October 5, 2013
Health Authority: Italy: The Italian Medicines Agency

Additional relevant MeSH terms:
Cerebral Hemorrhage
Hemorrhage
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Intracranial Hemorrhages
Nervous System Diseases
Pathologic Processes
Vascular Diseases

ClinicalTrials.gov processed this record on November 19, 2014